Daniel Franzen

2.0k total citations
111 papers, 1.3k citations indexed

About

Daniel Franzen is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Physiology. According to data from OpenAlex, Daniel Franzen has authored 111 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Pulmonary and Respiratory Medicine, 20 papers in Surgery and 16 papers in Physiology. Recurrent topics in Daniel Franzen's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (22 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (18 papers) and Tracheal and airway disorders (16 papers). Daniel Franzen is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (22 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (18 papers) and Tracheal and airway disorders (16 papers). Daniel Franzen collaborates with scholars based in Switzerland, United States and Germany. Daniel Franzen's co-authors include Malcolm Kohler, Michele Genoni, Lutz Freitag, Christian F. Clarenbach, Paul Vogt, Andreas Künzli, Burkhardt Seifert, U Niederhäuser, Rolf Jenni and Marko Turina and has published in prestigious journals such as Nature Communications, PLoS ONE and Scientific Reports.

In The Last Decade

Daniel Franzen

103 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Franzen Switzerland 19 587 298 223 210 202 111 1.3k
Tetsu Yamada Japan 24 453 0.8× 916 3.1× 159 0.7× 83 0.4× 44 0.2× 122 1.6k
Takashi Noguchi Japan 19 191 0.3× 504 1.7× 381 1.7× 43 0.2× 39 0.2× 127 1.5k
Amulya K. Saxena United Kingdom 25 371 0.6× 1.6k 5.2× 99 0.4× 98 0.5× 28 0.1× 177 2.0k
Paulo Manuel Pêgo‐Fernandes Brazil 21 893 1.5× 1.1k 3.8× 199 0.9× 138 0.7× 368 1.8× 262 1.9k
Maryam Ghadimi Mahani United States 16 350 0.6× 334 1.1× 230 1.0× 23 0.1× 261 1.3× 51 949
Hendrik T. Tevaearai Switzerland 27 451 0.8× 1.2k 4.0× 227 1.0× 70 0.3× 833 4.1× 101 2.4k
Pierce A. Grace Ireland 20 676 1.2× 864 2.9× 129 0.6× 47 0.2× 244 1.2× 54 1.5k
Wei-Jen Shih United States 19 355 0.6× 273 0.9× 126 0.6× 47 0.2× 209 1.0× 171 1.4k
Gernot Seebacher Austria 22 439 0.7× 1.4k 4.5× 229 1.0× 20 0.1× 301 1.5× 49 1.8k
Marcel Binnebösel Germany 30 460 0.8× 1.8k 6.1× 129 0.6× 78 0.4× 61 0.3× 106 2.4k

Countries citing papers authored by Daniel Franzen

Since Specialization
Citations

This map shows the geographic impact of Daniel Franzen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Franzen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Franzen more than expected).

Fields of papers citing papers by Daniel Franzen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Franzen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Franzen. The network helps show where Daniel Franzen may publish in the future.

Co-authorship network of co-authors of Daniel Franzen

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Franzen. A scholar is included among the top collaborators of Daniel Franzen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Franzen. Daniel Franzen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Egenod, Thomas, et al.. (2024). The Use of Bronchial Rheoplasty in Emphysema Patients Previously Treated with Endoscopic Lung Volume Reduction: A Case Series. International Journal of COPD. Volume 19. 1791–1797. 1 indexed citations
3.
Kronen, Peter, Adva Krivitsky, Nevena Paunović, et al.. (2024). Effects of shape and structure of a new 3D-printed personalized bioresorbable tracheal stent on fit and biocompatibility in a rabbit model. PLoS ONE. 19(6). e0300847–e0300847. 1 indexed citations
4.
Franzen, Daniel, et al.. (2024). Ultrasound-guided transbronchial cryobiopsy of mediastinal and hilar lesions: a multicenter pragmatic cohort study with real-world evidence. BMJ Open Respiratory Research. 11(1). e002617–e002617. 6 indexed citations
5.
Franzen, Daniel, et al.. (2024). Endoscopic treatment of benign tracheal stenosis: a single-centre study. Swiss Medical Weekly. 154(6). 3363–3363.
6.
Gaspert, Ariana, René Hage, Bart Vrugt, et al.. (2022). Transbronchial Cryobiopsy Compared to Forceps Biopsy for Diagnosis of Acute Cellular Rejection in Lung Transplants: Analysis of 63 Consecutive Procedures. Life. 12(6). 898–898. 9 indexed citations
7.
Franzen, Daniel. (2022). Cost-effectiveness analysis of surgical lung volume reduction compared with endobronchial valve treatment in patients with severe emphysema. Swiss Medical Weekly. 152(4546). 40008–40008. 1 indexed citations
8.
Sievi, Noriane A., Alexandra Schneider, Martin Osswald, et al.. (2022). The prevalence of obstructive sleep apnea in sarcoidosis and its impact on sleepiness, fatigue, and sleep-associated quality of life: a cross-sectional study with matched controls (the OSASA study). Journal of Clinical Sleep Medicine. 18(10). 2415–2422. 5 indexed citations
9.
10.
Caviezel, Claudio, Henrik Jessen Hansen, Michael Perch, et al.. (2020). Lung volume reduction surgery as salvage procedure after previous use of endobronchial valves. Interactive Cardiovascular and Thoracic Surgery. 32(2). 263–269. 5 indexed citations
11.
Franzen, Daniel, et al.. (2018). Complications after bronchoscopic lung volume reduction. Journal of Thoracic Disease. 10(S23). S2811–S2815. 9 indexed citations
12.
Freitag, Lutz, Paul Zarogoulidis, Kaid Darwiche, et al.. (2017). Towards Individualized Tracheobronchial Stents: Technical, Practical and Legal Considerations. Respiration. 94(5). 442–456. 64 indexed citations
13.
Markun, Stefan, Daniel Franzen, Kaba Dalla Lana, et al.. (2017). Acute exacerbated COPD: room for improvement in key elements of care. International Journal of COPD. Volume 12. 2969–2975. 6 indexed citations
14.
Franzen, Daniel, Albina Nowak, Sarah R. Haile, et al.. (2017). Long-term follow-up of pulmonary function in Fabry disease: A bi-center observational study. PLoS ONE. 12(7). e0180437–e0180437. 10 indexed citations
15.
Franzen, Daniel, et al.. (2017). Evaluation of Nickel Release from Endobronchial Valves as a Possible Cause of Hypersensitivity Pneumonitis in a Patient Treated with Bronchoscopic Lung Volume Reduction. International Archives of Allergy and Immunology. 174(3-4). 144–150. 5 indexed citations
16.
Grande, Bastian, Michaela Kolbe, Christoph B. Nöthiger, et al.. (2016). SafAIRway. Medicine. 95(23). e3849–e3849. 8 indexed citations
17.
Gräni, Christoph, Oliver Senn, Pietro E. Cippà, et al.. (2015). Diagnostic performance of reproducible chest wall tenderness to rule out acute coronary syndrome in acute chest pain: a prospective diagnostic study. BMJ Open. 5(1). e007442–e007442. 21 indexed citations
18.
Clarenbach, Christian F., Daniel Franzen, Malcolm Kohler, & Noriane A. Sievi. (2015). Physical inactivity and arterial stiffness in COPD. International Journal of COPD. 10. 1891–1891. 17 indexed citations
19.
Franzen, Daniel, Fabrice E. Graf, Simon Wieser, et al.. (2014). Hospital care patterns in the management of acute exacerbated chronic obstructive pulmonary disease - A retrospective analysis from Zurich, Switzerland. European Respiratory Journal. 44(Suppl 58). P795–P795. 1 indexed citations
20.
Franzen, Daniel, et al.. (2013). Pulmonary involvement in Fabry disease: Overview and perspectives. European Journal of Internal Medicine. 24(8). 707–713. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tetsu Yamada Breakdown of academic impact, for papers by Takashi Noguchi Breakdown of academic impact, for papers by Amulya K. Saxena Breakdown of academic impact, for papers by Paulo Manuel Pêgo‐Fernandes Breakdown of academic impact, for papers by Maryam Ghadimi Mahani Breakdown of academic impact, for papers by Hendrik T. Tevaearai Breakdown of academic impact, for papers by Pierce A. Grace Breakdown of academic impact, for papers by Wei-Jen Shih Breakdown of academic impact, for papers by Gernot Seebacher Breakdown of academic impact, for papers by Marcel Binnebösel
Rankless by CCL
2026